Leite et al., 2021 - Google Patents
Combined transcriptome and proteome leukocyte's profiling reveals up-regulated module of genes/proteins related to low density neutrophils and impaired …Leite et al., 2021
View HTML- Document ID
- 17970942794040431647
- Author
- Leite G
- Ferreira B
- Tashima A
- Nishiduka E
- Cunha-Neto E
- Brunialti M
- Assuncao M
- Azevedo L
- Freitas F
- van der Poll T
- Scicluna B
- Salomão R
- Publication year
- Publication venue
- Frontiers in immunology
External Links
Snippet
Sepsis is a global health emergency, which is caused by various sources of infection that lead to changes in gene expression, protein-coding, and metabolism. Advancements in “omics” technologies have provided valuable tools to unravel the mechanisms involved in …
- 102000004169 proteins and genes 0 title abstract description 102
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aschenbrenner et al. | An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells | |
Leite et al. | Combined transcriptome and proteome leukocyte’s profiling reveals up-regulated module of genes/proteins related to low density neutrophils and impaired transcription and translation processes in clinical sepsis | |
Daamen et al. | Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway | |
Vanderbeke et al. | Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity | |
Li et al. | Whole‐transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID‐19 patients | |
Saris et al. | Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19 | |
Schmiedel et al. | COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types | |
Boucheron et al. | CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2 | |
Giannella et al. | Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients | |
Errington et al. | A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach | |
Graessel et al. | A combined omics approach to generate the surface atlas of human naive CD4+ T cells during early T-cell receptor activation | |
Malengier-Devlies et al. | Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates | |
Li et al. | New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation | |
Martin-Sanchez et al. | Immunological biomarkers of fatal COVID-19: a study of 868 patients | |
Garcia-Gonzalez et al. | Dysregulated immune responses in COVID-19 patients correlating with disease severity and invasive oxygen requirements | |
Moorlag et al. | Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity | |
Rice et al. | Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19 | |
Zhou et al. | Quantitative proteomic profile of psoriatic epidermis identifies OAS2 as a novel biomarker for disease activity | |
Wang et al. | LOC152742 as a biomarker in the diagnosis of pulmonary tuberculosis infection | |
Schubert et al. | A multi-omics analysis of mucosal-Associated-Invariant T cells reveals key drivers of distinct modes of activation | |
Sfikakis et al. | Blood transcriptomes of anti-SARS-CoV-2 antibody-positive healthy individuals who experienced asymptomatic versus clinical infection | |
Meng et al. | MX2: Identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus | |
Bingham et al. | High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis | |
Sumida et al. | An autoimmune transcriptional circuit drives FOXP3+ regulatory T cell dysfunction | |
Lee et al. | Role of lymphoid lineage cells aberrantly expressing alarmins S100A8/A9 in determining the severity of COVID-19 |